Skip to main content
FinSpry Logo
FinSpry
ASTH logo
ASTH
(NASDAQ)
Astrana Health, Inc.
$40.99-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Astrana Health (ASTH) Stock Price & Financial Analysis

Astrana Health Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$38.95 - $41.83
52-Week High$51.60
52-Week Low$18.08
Open$41.62
Volume869.86K
Average Volume (3M)733.86K
Market Cap2.06B
Shares Outstanding49.05M
P/E Ratio (TTM)73.18
Forward P/E80.05
Price to Sales (P/S)0.63
Price to Book (P/B)2.76
EV/EBITDA17.92
Revenue (TTM)3.53B
Net Income (TTM)30.23M
Free Cash Flow (TTM)154.99M
EPS (TTM)$0.65
Profit Margin0.86%
Operating Margin2.45%
Return on Equity (ROE)3.78%
Debt to Equity1.33
50-Day MA$41.09
200-Day MA$29.85
52-Week Change82.67%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Astrana Health

What is the current stock price for ASTH?

As of the latest trading session, ASTH stock trades at $40.99. The 52-week range is $18.08–$51.60, with a day range of $38.95–$41.83.

What is the P/E ratio for ASTH?

Astrana Health's trailing P/E ratio is 73.2, meaning investors pay $73.2 for every $1 of annual earnings. The forward P/E is 80.0, reflecting analyst expectations for future earnings. Astrana Health operates in the Healthcare sector.

Does ASTH pay dividends?

Astrana Health does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ASTH?

Based on 9 analysts, the consensus for ASTH is Buy.

What is the market cap of ASTH?

Astrana Health's market capitalization is $2.01B, classifying it as a mid-cap company. Astrana Health operates in the Healthcare sector within the Medical Care Facilities industry.